Rapport Therapeutics (RAPP) Price to Earnings (2024 - 2026)
Analysis
Rapport Therapeutics (RAPP) Price to Earnings (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.30 Bn | 131.45 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.70 Bn | 77.70 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.33 Bn | 1.37 Bn |
| 4 | Moderna | 58.00 Bn | 52.86 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.23 Bn | 31.93 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Rapport Therapeutics | 2.22 Bn | 2.22 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.30 |
| Mar 31, 2026 | -75.33 |
| Dec 31, 2025 | -34.99 |
| Sep 30, 2025 | -41.84 |
| Jun 30, 2025 | -15.52 |
| Mar 31, 2025 | -15.21 |
| Dec 31, 2024 | -18.41 |
| Sep 30, 2024 | -42.71 |
| Jun 30, 2024 | -13.69 |